Peak Processing Limited · ASX:PKP
Peak Processing — PAC Partners Hong Kong Conference 2019
19 slides from Peak Processing's conference presentation, Jun 12, 2019
Slide 1: Althea Group Holdings Limited – PAC Partners Hong Kong Conference June 2019
Althea Group Holdings Limited (ASX:AGH) PAC Partners Hong Kong Conference | June 2019
Slide 2: Access Made Simple
ESTABLISHED Australian licensed producer, supplier and exporter of pharmaceutical grade medicinal cannabis EDUCATION Providing medicinal cannabis education access and management services Supporting eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways EXP
Slide 3: Key Market Statistics | Listed on ASX: 21 September 2018
Althea Group Holdings Limited (ASX:AGH) Key Market Statistics | Listed on ASX: 21 September 2018 Key Market Statistics¹ Share Price Performance | September 2018 - June 2019 Top Shareholders 0.8 Joshua Fegan (CEO) 28% ASX code AGH 0.7 Aphria Inc. (NYSE:APHA) 25% Listing price (Date of $0.20 0.6 listi
Slide 4: Experienced & Relevant Leadership Team
Althea Group Holdings Limited (ASX:AGH) Experienced & Relevant Leadership Team Andrew Newbold Joshua Fegan Penny Dobson Alan Boyd Chairman & Independent Chief Executive Officer Independent Non-Executive Independent Non-Executive Non-Executive & Founder Director Director • Extensive experience as dir
Slide 5: Full Suite Of Licences from The Office of Drug Control (ODC)
Althea Group Holdings: Licenses Full Suite Of Licences from The Office of Drug Control (ODC) Althea has been granted the full suite of licenses for pharmaceutical grade medicinal cannabis from The Office of Drug Control (ODC) in Australia Althea: Producing, Cultivating, Manufacturing Althea has the
Slide 6: Pharmaceutical Grade Medicinal Cannabis Products
Althea Group Holdings: Products Pharmaceutical Grade Medicinal Cannabis Products Althea strives to ensure patients are supplied with pharmaceutical grade, full spectrum, medicinal cannabis products The safety, consistency and quality of Althea medicinal cannabis is ensured by Seed-to-Sale Certificat
Slide 7: Providing Medicinal Cannabis Education Access & Management Services
Althea Group Holdings: Education Providing Medicinal Cannabis Education Access & Management Services Althea Concierge is supported in the field by our team of Medical Science Liaisons who work face-to-face with healthcare professionals How can I find a doctor to prescribe medicinal cannabis for my c
Slide 8: Providing Medicinal Cannabis Education Access & Management Services
Althea Group Holdings: Education Providing Medicinal Cannabis Education Access & Management Services Simplifying access to medicinal cannabis for patients, HCPS and pharmacists (Australian example) Patients Althea Concierge launched September 2018: • Find doctors and information on accessing • Creat
Slide 9: Althea Concierge has been a godsend for doctors in Australia
“Althea Concierge has been a godsend for doctors in Australia who otherwise would not have the time or capacity to submit applications on behalf of patients, which is required before they can prescribe medicinal cannabis. We have feedback from prescribing doctors that they are able to complete appli
Slide 10: MEDIC | HCP Education Platform
Althea Group Holdings: Education Providing Medicinal Cannabis Education Access & Management Services MEDIC | HCP Education Platform • MEDIC is an online portal offering free, evidence-based education and resources on: o The endocannabinoid system o Safety and clinical considerations o Management of
Slide 11: Medicinal Cannabis: Treatment Increasing Evidence Of Effectiveness
Medicinal Cannabis: Treatment Increasing Evidence Of Effectiveness Medicinal cannabis products are accepted as being effective in the treatment of certain medical conditions including chronic pain, sleep & mood disorders, mental health, nausea, vomiting, epilepsy, and pain & spasticity caused by mul
Slide 12: Medicinal Cannabis: History & Outlook in Australia
Medicinal Cannabis: History & Outlook in Australia Increasing Usage & Growing Industry For doctors, the Therapeutic Goods Administration's (TGA) special Cannabis on track to become a $1.2 billion access scheme requires an application form to be filled out for industry over the next 10 years each pat
Slide 13: Althea in Australia: Accelerating Patient & Prescriber Growth
Medicinal Cannabis: Althea in Australia Accelerating Patient & Prescriber Growth Althea’s Accelerating Patient Growth in Australia Althea’s Accelerating Doctor Growth in Australia 13 Althea Group Holdings Limited (ASX:AGH) | PAC Partners Hong Kong Conference - June 2019
Slide 14: Case Studies: Althea in Australia
Case Studies: Althea in Australia Real Patients Using Medicinal Cannabis With Real Results Patient: 8 year-old boy | Indication: Autism and ADHD • Patient had seen multiple Psychiatrists, Neurologists, Paediatricians in both private and public hospital clinics with no success in treating his severe
Slide 15: Althea in the United Kingdom: Expanding Operations
Medicinal Cannabis: Althea in the United Kingdom Expanding Operations To Accommodate Patient Access Althea’s Opportunity: United Kingdom The United Kingdom’s highly regulated framework for Althea is one of the first medicinal cannabis prescribing, supplying and possessing medicinal cannabis companie
Slide 16: Althea Launches UK Concierge Platform
Medicinal Cannabis: Althea in the United Kingdom Expanding Operations To Accommodate Patient Access ASX Announcement | 31 May 2019 Althea Launches UK Concierge Platform Commences First Assessments of Patients in the UK Investment Highlights • Althea Concierge UK launches successfully with doctors al
Slide 17: International Strategic Growth Initiatives: Export & Emerging Markets
Althea's International Strategic Growth Initiatives Export & Emerging Market Opportunities • AUSTRALIA: Export of medicinal cannabis products from Australia is permitted under the Narcotic Drugs Amendment (Cannabis) Regulations 2018 • Export enhances the viability of the Australian medicinal cannabi
Slide 18: Access Made Simple – Contact Details
Althea Group Holdings Limited (ASX:AGH) ACCESS MADE SIMPLE www.althea.life Althea Group Holdings Limited Josh Fegan, Joshua Fegan, CEO CEO & Managing & ManagingDirector Director 1300 70 20 20 | contact@althea.com.au Investors: PAC Partners Securities 03 8633 9834 | enquiries@pacpartners.com.au Media
Slide 19: Legal Disclaimer
Althea Group Holdings Legal Disclaimer Althea Group Holdings Limited ACN 626 966 943 (Company) has prepared this presentation (Presentation) dated 12 June 2019 to provide current and prospective investors in the Company with an update in relation to the Company, its subsidiaries and their activities
Peak Processing — PAC Partners Hong Kong Conference 2019 on 6ix